Michael J. Cannavoeditorial@labpulse.comInfectiousHow can digital imaging help in the coronavirus crisis?The COVID-19 pandemic has exposed critical flaws and bottlenecks in healthcare. Test results are taking too long to deliver to doctors and patients, in-person encounters expose both patients and healthcare providers to infection, and healthcare personnel in outbreak hotspots are overwhelmed while those in less impacted locations await the call to action.April 5, 2020Pathology, histologyShared systems enable digital pathology deployments: Part 2Reducing the total cost of a DPS by $200,000 or more by sharing the different components of enterprise imaging systems (EIS) puts an investment more within reach financially. That said, you need to show more than just a financial return on investment to get any new clinical system implemented.February 20, 2020Pathology, histologyShared systems enable digital pathology deployments: Part 1In radiology and cardiology, enterprise imaging systems (EIS), better known as PACS, have transformed the way studies are interpreted, stored, and shared. The same can be said for electronic medical record (EMR) systems that allow data to be mined and assist in patient diagnoses. Having access to all clinical data is especially crucial as artificial intelligence (AI) systems are starting to play a larger role in the radiology interpretation process. Yet digital pathology systems (DPS) seem to lag behind in terms of adoption.February 19, 2020Page 1 of 1Top StoriesCancerInvivoscribe, Complete Genomics partner to develop NGS tests for cancer research, detectionUnder the terms of the deal, Invivoscribe will be responsible for the development of biomarker tests, including test controls and associated bioinformatics software. The tests will run on Complete Genomics' NGS platforms.Regulatory ApprovalSeegene obtains IVDR certification for 30 diagnostic assaysPolicy and RegulationAdvocacy groups in letter urge FDA to develop regulations for lab-developed testsCollaborationNucleai, Adlai Nortye collaborate on biomarkers for clinical trialsSponsor ContentVisit our Molecular Diagnostics Community
